8th Antibody Industrial Symposium

8th Antibody Industrial Symposium
November 23-24, 2020 – Now Virtual !
Registration is open!

Following the latest updates on the evolution of the Covid-19 health situation, MabImprove and MabDesign have thus decided to virtualized this edition of the AIS congress. We will thus provide you a virtual event congress featuring online sessions, video virtual networking, poster session on the same dates of the event.

We hope you can joins us virtually !

The program of the AIS2020 edition will focus on “Multispecific Antibodies, Ab-like Molecules & Adoptive Cell therapy for Fighting Diseases”, with keynote lectures, pitch talks of new creative projects, and industrial talks from big pharmaceutical companies. Furthermore, it will be possibility to set up, through an online platform, business meetings during both days (partnering).

The topics covered during this meeting are:

  • Multimer derivates (multimer nanobides and Abs, BiTES, NKCE, gamma/delta T Cells engagers and beyond);
  • Adoptive cell therapy (CAR-T cells, CARN-NK and more);
  • Immunocytokines, actakines, fusions and other alternative formats;
  • Complexe Biologics CMC and Developability;
  • From Preclincal to Drug Approval;

The purpose of this congress is to foster interactions between academic labs and pharmaceutical industries in the field of therapeutic antibodies. Last edition, the AIS2019, counted with the presence of more than 350+ participants from 15 different countries representing more than 170+ organizations and with 450+ BtoB meetings taken place.

Several sponsorship packages with presentation slots, exhibition space, company visibility in media supports and access to all the conference events are available!

Registration is OPEN!

 

S'inscrire

Date

November 23-24, 2020

Lieu

Digital

Organisateur

LabEx MabImprove & MabDesign

Contact